However, PD‐L1 expression has not been found to be correlated with the pathological response to neoadjuvant anti‐PD‐1 therapy in resectable NSCLC, although it is associated with the response in advanced NSCLC.4, 5. This evidence concerns the gene PDCD1 and non-small cell lung carcinoma.